THE GOOD PRACTICE
KINGS ROAD, LONDON
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 12 | 13 | 92.3% | |
| CKD 4 | 2008 | 12 | 12 | 100.0% | |
| CKD 5 | 2009 | 9 | 10 | 90.0% | |
| CKD 5 | 2010 | 4 | 4 | 100.0% | |
| CKD 5 | 2011 | 3 | 3 | 100.0% | |
| CKD 5 | 2012 | 1 | 1 | 100.0% | |
| CKD 5 | 2013 | 3 | 3 | 100.0% | |
| CKD003 | 2014 | 3 | 3 | 100.0% | |
| CKD003 | 2015 | 3 | 3 | 100.0% | |
| NM84 | 2016 | 1 | 1 | 100.0% | |
| NM84 | 2017 | 1 | 4 | 25.0% | |
| NM84 | 2018 | 3 | 5 | 60.0% | |
| NM84 | 2019 | 7 | 9 | 77.8% | |
| NM84 | 2020 | 6 | 8 | 75.0% | |
| NM84 | 2022 | 7 | 9 | 77.8% | |
| NM84 | 2023 | 7 | 9 | 77.8% |
